- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03126955
Diagnostic Test of Choice for HELPS Syndrome
Microvascular Decompression for HELPS Syndrome: What is the Best Diagnostic Test?
Study Overview
Status
Conditions
Detailed Description
The treatment of HELPS syndrome begins with the correct diagnosis. Some patients are able to localize the side of their symptoms in HELPS syndrome while others are unable to. The purpose of this study is to prospectively study which of the following is the diagnostic test of choice for patients who are unable to localize their HELPS: 1. CISS MRI sequences, 2. interictal laryngoscopy, and 3. unilateral and contralateral Botox injections separated 3-months apart.
Both neuroradiologist and otolaryngologist will be blinded to the outcome of surgery and be asked "based on your diagnostic test, which side do you believe we should perform MVD surgery?"
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V5Z 1M9
- Vancouver General Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
HELPS (Hemi-Laryngo-Pharyngeal Spasm) Syndrome
-Subgroup of patients who are unable to localize lateralization of throat contractions
Description
Inclusion Criteria:
- Patients diagnosed with HELPS as described in our initial publication (Honey et al. 2016)
- Patients unable to localize the side of their HELPS syndrome
Exclusion Criteria:
- Unable to provide informed consent
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
HELPS Syndrome unable to lateralize contractions
Each patient will have the following 3 diagnostic pre-operative tests: i) MRI (CISS sequence), ii) video laryngoscopy, and iii) sequential Botox injections in their throat (left side and then 3 months later on the right side).
|
Compare pre-operative MRI diagnosis to intra-operative findings on if both are in agreement
Compare pre-operative laryngoscopy diagnosis to intra-operative findings on if both are in agreement
Compare pre-operative diagnosis using Botox to intra-operative findings on if both are in agreement
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pre-Operative CISS MRI (One month before surgery) compared to Intraoperative Findings
Time Frame: Pre-Operative and Intra-Operative
|
Determine if CISS MRI sequence lateralization in concordance with intraoperative findings
|
Pre-Operative and Intra-Operative
|
|
Pre-Operative Interictal Laryngoscopy (One month before surgery) compared to Intraoperative Findings
Time Frame: Pre-Operative vs. Intra-Operative
|
Determine if interictal laryngoscopy in concordance with intraoperative findings
|
Pre-Operative vs. Intra-Operative
|
|
Pre-Operative 3 and 6-month Botox Injections compared to Intraoperative Findings
Time Frame: Pre-operative 3 and 6 months vs. Intra-Operative
|
Determine if unilateral vs contralateral Botox-induced symptom reduction in concordance with intraoperative findings
|
Pre-operative 3 and 6 months vs. Intra-Operative
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Christopher R Honey, MD, DPhil, FRCSC, University of British Columbia
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H17-00953
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HELPS Syndrome
-
GlaxoSmithKlineNot yet recruiting
-
Rutgers, The State University of New JerseyRecruitingMicrodeletion 3q29 Syndrome | Microduplication 3q29 SyndromeUnited States
-
Lokman Hekim UniversityCompletedSubacromial Impingement Syndrome | Shoulder Impingement Syndrome | Rotator Cuff Impingement SyndromeTurkey (Türkiye)
-
Unravel Biosciences, Inc.RecruitingPitt Hopkins SyndromeColombia
-
Neumedicines Inc.Department of Health and Human ServicesCompletedHematopoietic Syndrome Due to Acute Radiation SyndromeUnited States
-
Cairo UniversityCompleted
-
Cairo UniversityCompleted
-
Ministry of Public Health, Democratic Republic...National Institutes of Health (NIH); Oregon Health and Science University; National... and other collaboratorsCompletedNeurotoxicity Syndrome, Cassava | Neurotoxicity Syndrome, Cyanate | Neurotoxicity Syndrome, Cyanide | Neurotoxicity Syndrome, ThiocyanateCongo, The Democratic Republic of the
-
Charite University, Berlin, GermanyRecruiting
-
Neuren Pharmaceuticals LimitedRecruitingPhelan-McDermid SyndromeUnited States
Clinical Trials on Pre-Operative CISS-MRI Sequences
-
University Hospital, AngersUniversity AngersRecruitingNon-alcoholic Fatty Liver Disease NAFLDFrance
-
King's College Hospital NHS TrustKing's College London; Erasmus Medical CenterNot yet recruiting
-
University Hospital, BordeauxCompleted
-
Fondation Ophtalmologique Adolphe de RothschildRecruitingDescription of Local Modifications of Lymph Nodes or Bundles With the FABIR Sequence in MRIFrance
-
University of ZurichSwiss National Science FoundationCompleted
-
CNAO National Center of Oncological HadrontherapyDept. of Electronics, Informatics, Bioengineering, Politecnico di Milano,...Recruiting
-
Fondation Ophtalmologique Adolphe de RothschildCompletedPre and Post-arterial Recanalization Imaging of Central Retinal Artery Occlusions (CRAO) (I-RECANAL)Magnetic Resonance Imaging | Diagnosis | Prognosis | Retinal Artery Occlusion | EtiologyFrance
-
Great Ormond Street Hospital for Children NHS Foundation...CompletedCerebellar Mutism | Posterior Fossa SyndromeUnited Kingdom
-
University Hospital, CaenRecruitingMemory DisordersFrance